For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.

21st Oct 09

Chairman's Address to AGM

Chairman's Address to the 2009 Annual General Meeting held on 21 October 2009


Read full media release - pdf
18th Sep 09

Second Cystic Fibrosis Trial Passes Recruitment Target

Pharmaxis (ASX:PXS) today announced that its second pivotal Phase 3 clinical trial of Bronchitol for the treatment of cystic fibrosis has now passed its recruitment target of 300 subjects. The first efficacy data from the trial is expected to be available during the first half of 2010.


Read full media release - pdf
11th Sep 09

Pharmaxis to Present at European Respiratory Society Meeting

Pharmaceutical company Pharmaxis (ASX:PXS) has announced that the results from the recently completed Phase III trial of Bronchitol in cystic fibrosis will be presented in a late-breaking oral presentation at the 2009 European Respiratory Society congress in Vienna.

In addition, research scientists from various respiratory laboratories around the world will present data at thematic poster sessions on the use of Aridol in different settings.


Read full media release - pdf